Spots Global Cancer Trial Database for partially platinum sensitive
Every month we try and update this database with for partially platinum sensitive cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients | NCT01624493 | Ovarian Cancer | Carboplatin Gemcitabine Carboplatin Gemcitabine BNC105P | 18 Years - | Hoosier Cancer Research Network | |
BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients | NCT01624493 | Ovarian Cancer | Carboplatin Gemcitabine Carboplatin Gemcitabine BNC105P | 18 Years - | Hoosier Cancer Research Network | |
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients | NCT02855944 | Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | Chemotherapy Rucaparib | 18 Years - | pharmaand GmbH | |
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients | NCT02855944 | Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | Chemotherapy Rucaparib | 18 Years - | pharmaand GmbH |